Şunu aradınız:: ġenotossiċi (Maltaca - İngilizce)

tmz jista’ jkollu effetti ġenotossiċi.
tmz can have genotoxic effects.

trabectedin jista’ jkollu effetti ġenotossiċi.
trabectedin can have genotoxic effects.

l-identifikazzjoni bikrija ta’ karċinoġeni ġenotossiċi
the early identification of genotoxic carcinogens

paliperidone palmitate u paliperidone ma kinux ġenotossiċi.
paliperidone palmitate and paliperidone were not genotoxic.

studji ġenotossiċi wrew li ribavirin għandu xi effetti ġenotossiċi.
genotoxicity studies have demonstrated that ribavirin does exert some genotoxic activity.

studji ġenotossiċi ma wrew l-ebda attivita mutaġenika jew klastoġenika.
genotoxicity studies have not detected any mutagenic or clastogenic activity.

ma kienu osservati l-ebda effetti ġenotossiċi b’eptifibatide.
no genotoxic effects were observed with eptifibatide.

studji ġenotossiċi ma indikaw l-ebda potenzjal mutaġeniku għal nintedanib.
genotoxicity studies indicated no mutagenic potential for nintedanib.

b’mod ġenerali, radjunukleidi huma kkunsidrati bħala ġenotossiċi u karċinoġeniċi.
in general, radionuclides are considered to be genotoxic and carcinogenic.

bħal ċitostatiċi ġenotossiċi oħrajn, paclitaxel jista’ jkollu effetti ġenotossiċi.
like other genotoxic cytostatics, paclitaxel can have genotoxic effects.

studji ġenotossiċi li saru biex jittestjaw għal impuritajiet ġenotossiċi potenzjali kienu wkoll negattivi.
genotoxicity studies conducted to test for potentially genotoxic impurities were also negative.

- qed jirċievi xi terapija konkomitanti li tinkludi karatteristiċi epatotossiċi u/ jew ġenotossiċi
- is receiving a concomitant therapy including hepatotoxic and/ or genotoxic properties

artenimol u piperaquine ma kinux ġenotossiċi / klastoġeniċi bbażat fuq ittestjar in vitro u in vivo
artenimol and piperaquine were not genotoxic/clastogenic based on in vitro and in vivo testing.

ponatinib ma wriex karatteristiċi ġenotossiċi meta evalwat fis-sistemi standard in vitro u in vivo.
ponatinib did not exhibit genotoxic properties when evaluated in the standard in vitro and in vivo systems.

batterija standard ta’ testijiet ġenotossiċi ma wriet l-ebda periklu speċifiku għal bnedmin.
a standard battery of genotoxicity test reveals no specific hazard for humans.

saxagliptin ma kienx ġenotossiku f’serje konvenzjonali ta’ studji ġenotossiċi in vitro u in vivo.
saxagliptin was not genotoxic in a conventional battery of genotoxicity studies in vitro and in vivo.

porfimer sodium ma kienx mutaġeniku f’testijiet ġenotossiċi standard fl-assenza tad-dawl.
porfimer sodium was not mutagenic in standard genotoxicity tests in the absence of light.

cabozantinib ma wera l-ebda potenzjal mutaġeniku jew klastiġeniku f’batterija standard ta’ assaġġi ġenotossiċi.
cabozantinib has shown no mutagenic or clastogenic potential in a standard battery of genotoxicity assays.

tenofovir disoproxil fumarate kien pożittiv fi tnejn minn kull tliet studji ġenotossiċi in vitro iżda kien negattiv fl- analiżi mikronuklejari in vivo.
tenofovir disoproxil fumarate was positive in two out of three in vitro genotoxicity studies but negative in the in vivo micronucleus assay.

sensiela ta’ testijiet stàndard għall-ġenotossiċità ma wrew l-ebda effetti ġenotossiċi rilevanti bioloġikament għal febuxostat.
a standard battery of test for genotoxicity did not reveal any biologically relevant genotoxic effects for febuxostat.